Thrombolytic Medicines for Pulmonary EmbolismCurrent as of: December 6, 2017 |
|
Thrombolytic Medicines for Pulmonary EmbolismTopic OverviewThrombolytic medicines, such as streptokinase or tissue-type plasminogen activator (TPA), can dissolve blood clots. These medicines may be used to treat pulmonary embolism in life-threatening situations. All thrombolytics can cause serious bleeding. Bleeding inside the brain is a particular danger that can cause a stroke or death. In general, thrombolytics are used only where the risk of bleeding can be balanced against the risks of not dissolving the blood clot rapidly. Thrombolytics might be used when you have a large blood clot that is:
These medicines are given through a vein in the hand or arm. Sometimes it is necessary to insert a catheter and give the medicine directly into the pulmonary artery. You must be hospitalized to receive thrombolytic medicines. Related InformationReferences
Credits
ByHealthwise Staff Current as ofDecember 6, 2017
Current as of: December 6, 2017 |
Search the
Healthwise Knowledgebase Topic ContentsThis information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content. To learn more about Healthwise, visit Healthwise.org. © 1995-2018 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. |